EUVIMEDEUVIMED entdecken
Crossref

TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy

Philippa Garbutt, Sam Quill, Talia Greenbaum, Luis R Lopes, Julian D. Gillmore, Amand F. Schmidt

Cochrane Database of Systematic Reviews · 20.11.2026 · 2026 (11)

DOI: 10.1002/14651858.cd016420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cochrane Database of Systematic Reviews, online erschienen am 20.11.2026. Verfasst von Philippa Garbutt und 5 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Garbutt, P., Quill, S., Greenbaum, T., Lopes, L. R., Gillmore, J. D., & Schmidt, A. F. (2026). TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy. Cochrane Database of Systematic Reviews, 2026(11). https://doi.org/10.1002/14651858.cd016420

Vancouver

Garbutt P, Quill S, Greenbaum T, Lopes LR, Gillmore JD, Schmidt AF. TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy. Cochrane Database of Systematic Reviews. 2026;2026(11). doi:10.1002/14651858.cd016420

BibTeX
@article{Garbutt2026,
  author = {Garbutt, Philippa and Quill, Sam and Greenbaum, Talia and Lopes, Luis R and Gillmore, Julian D. and Schmidt, Amand F.},
  title = {TTR-stabilising medicines for the treatment of transthyretin amyloid cardiomyopathy},
  journal = {Cochrane Database of Systematic Reviews},
  year = {2026},
  volume = {2026},
  number = {11},
  doi = {10.1002/14651858.cd016420}
}
Kostenlos starten →